GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Retained Earnings

Cognetivity Neurosciences (XCNQ:CGN) Retained Earnings : C$-37.48 Mil (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Cognetivity Neurosciences's retained earnings for the quarter that ended in Oct. 2023 was C$-37.48 Mil.

Cognetivity Neurosciences's quarterly retained earnings declined from Apr. 2023 (C$-33.51 Mil) to Jul. 2023 (C$-35.44 Mil) and declined from Jul. 2023 (C$-35.44 Mil) to Oct. 2023 (C$-37.48 Mil).

Cognetivity Neurosciences's annual retained earnings declined from Jan. 2021 (C$-10.84 Mil) to Jan. 2022 (C$-23.97 Mil) and declined from Jan. 2022 (C$-23.97 Mil) to Jan. 2023 (C$-31.40 Mil).


Cognetivity Neurosciences Retained Earnings Historical Data

The historical data trend for Cognetivity Neurosciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Retained Earnings Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Retained Earnings
Get a 7-Day Free Trial -6.26 -8.91 -10.84 -23.97 -31.40

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.83 -31.40 -33.51 -35.44 -37.48

Cognetivity Neurosciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Cognetivity Neurosciences  (XCNQ:CGN) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Cognetivity Neurosciences (XCNQ:CGN) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines